GREGORY MIKUT: Open Payments
NPI 1114582590 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,152 in 44 payments from 17 companies in 2025. Trend: 2023 $679 · 2024 $783 · 2025 $1,152
Food & beverage: $1,152
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 1 | $179 |
| Novartis Pharmaceuticals Corporation | 8 | $145 |
| Abbott Laboratories | 6 | $138 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $128 |
| Baxter Healthcare | 2 | $96 |
| Boston Scientific Corporation | 3 | $75 |
| Amgen Inc. | 5 | $72 |
| CARDIVA MEDICAL, INC. | 2 | $59 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
Products named: SAPIEN 3 Ultra RESILIA, LEQVIO, LifeVest, ESPRIT, Hillrom - Carnation Ambulatory Monitor, REPATHA, CARDIVA VASCADE MVP VVCS 6-12F, General - Therapies.
Industry payments across AZ — which companies pay providers there.
